RenovoRx, Inc. (RNXT) Social Stream
RENOVORX INC (RNXT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering RENOVORX INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-20 | 2 | $16 | $15 | $15.5 | $1.73 | 795.95% |
| 2022-04-04 | 2 | $15 | $14 | $14.5 | $1.73 | 738.15% |
| 2022-10-18 | 2 | $14 | $9 | $11.5 | $1.73 | 564.74% |
| 2023-01-20 | 1 | $11 | $9 | $10 | $1.73 | 478.03% |
| 2023-03-09 | 1 | $14 | $9 | $11.5 | $1.73 | 564.74% |
| 2023-05-15 | 1 | $14 | $14 | $14 | $1.73 | 709.25% |
| 2023-08-18 | 1 | $13 | $13 | $13 | $1.73 | 651.45% |
| 2023-10-13 | 2 | $13 | $4 | $8.5 | $1.73 | 391.33% |
| 2023-11-15 | 2 | $7 | $7 | $7 | $1.73 | 304.62% |
| NA | 1 | $NA | $NA | $NA | $1.73 | NA% |
The Trend in the Analyst Price Target
Over the past 25 months, RNXT's average price target has gone down $8.5.
RNXT reports an average of 506.49% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 1 | 14 | 14 | 14.0 | 4.51 | 210.42% |
| 2023-05-15 | 1 | 14 | 14 | 14.0 | 2.23 | 527.8% |
| 2023-08-18 | 2 | 13 | 13 | 13.0 | 1.72 | 655.81% |
| 2023-08-18 | 1 | 13 | 13 | 13.0 | 1.72 | 655.81% |
| 2023-10-13 | 2 | 13 | 4 | 8.5 | 1.11 | 665.77% |
RNXT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
RNXT's average broker recommendation rating worsened by 1 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how RENOVORX INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 19.81% of that group.
- RENOVORX INC's upside potential (average analyst target price relative to current price) is greater than 1034.29% of all US stocks.
- RNXT has a lower variance in analysts' estimates than -84.36% of Pharmaceutical Products stocks.
- RENOVORX INC's average analyst price target is higher than 216.06% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RENOVORX INC are CNTX, IOBT, and NVCT.
View All Top Stocks by Price Target
Is RNXT a Buy, Hold or Sell? See the POWR Ratings now!